A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U.S. industry groups, including the United States Chamber of Commerce and Pharmaceutical Research and …
A woman who claimed in a lawsuit that GSK’s discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced. GSK said …
A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer. The ruling on Friday by Judge Vivian Medinilla of …
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation. The agreements cover cases in state …
Drugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding the cancer risks of their once-blockbuster heartburn drug Zantac, according to lawyers representing a Chicago woman in the first of thousands of such claims to go …
Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer, according to people familiar with the deal. The settlement was announced …
Sanofi SA said it has agreed to settle approximately 4,000 lawsuits accusing the French drugmaker of selling its Zantac heartburn medicine without warning patients that it could cause cancer. The pact, the first major resolution of cases related to the …
GSK Plc settled a US lawsuit set to start in California over the UK drugmaker’s blockbuster heartburn medication Zantac, the second such agreement this month. The company said it had reached a confidential settlement with claimants listed as Boyd/Steenvoord, resolving …
GSK Plc has settled a US lawsuit on heartburn medicine Zantac just weeks before the case was due to be heard in a court in California. The British drugmaker said it had reached a confidential settlement with David Browne and …
The first scheduled trial over claims that GSK Plc’s heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed by five months. The case, brought by California resident James Goetz in Alameda County Superior Court, …